Pharmacogenomics Market 2028 ByTechnology, Application, End-User | The Insight Partners

    Pharmacogenomics Market Forecast to 2028 - Covid-19 Impact and Global Analysis - byTechnology (DNA Sequencing, Microarray, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, Others); Application (Neurology, Oncology, Pain Management, Other); End-User (Biopharmaceutical Companies, Clinical Research Organizations/Contract Research Organizations, Contract Development and Manufacturing Organization (CDMO)

    Report Code: TIPRE00007564 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

    MARKET INTRODUCTION

    Pharmacogenomics is an essential characteristic feature of precision medicine, which allows for an individual's genetic makeup affects and their response to a therapeutic drug. Although tailor-made medication dosing, there still are a large number of cases involving adverse drug reactions, leading to frequent dose titration and iteration concerning treatment. With all these things, these factors impose a significant burden on the patient, provider, and the overall healthcare system.

    MARKET DYNAMICS

    The pharmacogenomics market is expected to grow significantly in the coming years, owing to the key factors such as rising research and development activities by the major pharmaceutical companies, and increasing focus on precision medicine. The developing regions are likely to serve more growth opportunities in coming years due to increasing in strategic initiative taken by key players.

    MARKET SCOPE

    The “Global Pharmacogenomics Market Analysis to 2028” is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of pharmacogenomics market with detailed market segmentation by type, application, end user and geography. The global pharmacogenomics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading pharmacogenomics market players and offers key trends and opportunities in the market.

    MARKET SEGMENTATION

    The global pharmacogenomics market is segmented on the basis of technology, application and end user. On the basis of technology, the market is segmented into DNA Sequencing, Microarray, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, Others. Based on the application the market is divided into Drug Discovery, Neurology, Oncology, Pain Management, Other. On the basis of end user, the market is segmented into biopharmaceutical companies, clinical research organizations/contract research organizations, and contract development and manufacturing organization (CDMO).
     



    Get more information on this report :

    REGIONAL FRAMEWORK

    The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Pharmacogenomics Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Pharmacogenomics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

    The report analyzes factors affecting Pharmacogenomics Market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Pharmacogenomics Market in these regions.
     



    Get more information on this report :

    MARKET PLAYERS

    The reports cover key developments in the pharmacogenomics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from pharmacogenomics market are anticipated to lucrative growth opportunities in the future with the rising demand for pharmacogenomics market in the global market. Below mentioned is the list of few companies engaged in the bioanalytical testing services market.

    The report also includes the profiles of key pharmacogenomics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

    • Abbott. 
    • bioMérieux SA
    • AstraZeneca
    • Bayer AG
    • BD
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche Ltd
    • Illumina, Inc.
    • QIAGEN.
    • Thermo Fisher Scientific Inc.


    The Insight Partner’s dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
     



    Get more information on this report :

    TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Pharmacogenomics Market - By Technology
    1.3.2 Pharmacogenomics Market - By Application
    1.3.3 Pharmacogenomics Market - By End-User
    1.3.4 Pharmacogenomics Market - By Region
    1.3.4.1 By Country
    2. KEY TAKEAWAYS
    3. RESEARCH METHODOLOGY
    4. PHARMACOGENOMICS MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PEST ANALYSIS
    4.2.1 North America - Pest Analysis
    4.2.2 Europe - Pest Analysis
    4.2.3 Asia-Pacific - Pest Analysis
    4.2.4 Middle East and Africa - Pest Analysis
    4.2.5 South and Central America - Pest Analysis
    4.3. EXPERT OPINIONS
    5. PHARMACOGENOMICS MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
    6. PHARMACOGENOMICS MARKET - GLOBAL MARKET ANALYSIS
    6.1. PHARMACOGENOMICS - GLOBAL MARKET OVERVIEW
    6.2. PHARMACOGENOMICS - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING/MARKET SHARE
    7. PHARMACOGENOMICS MARKET - REVENUE AND FORECASTS TO 2028 – TECHNOLOGY
    7.1. OVERVIEW
    7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
    7.3. DNA SEQUENCING
    7.3.1. Overview
    7.3.2. DNA Sequencing Market Forecast and Analysis
    7.4. MICROARRAY
    7.4.1. Overview
    7.4.2. Microarray Market Forecast and Analysis
    7.5. POLYMERASE CHAIN REACTION
    7.5.1. Overview
    7.5.2. Polymerase Chain Reaction Market Forecast and Analysis
    7.6. ELECTROPHORESIS
    7.6.1. Overview
    7.6.2. Electrophoresis Market Forecast and Analysis
    7.7. MASS SPECTROMETRY
    7.7.1. Overview
    7.7.2. Mass Spectrometry Market Forecast and Analysis
    7.8. OTHERS
    7.8.1. Overview
    7.8.2. Others Market Forecast and Analysis
    8. PHARMACOGENOMICS MARKET - REVENUE AND FORECASTS TO 2028 – APPLICATION
    8.1. OVERVIEW
    8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
    8.3. NEUROLOGY
    8.3.1. Overview
    8.3.2. Neurology Market Forecast and Analysis
    8.4. ONCOLOGY
    8.4.1. Overview
    8.4.2. Oncology Market Forecast and Analysis
    8.5. PAIN MANAGEMENT
    8.5.1. Overview
    8.5.2. Pain Management Market Forecast and Analysis
    8.6. OTHER
    8.6.1. Overview
    8.6.2. Other Market Forecast and Analysis
    9. PHARMACOGENOMICS MARKET - REVENUE AND FORECASTS TO 2028 – END-USER
    9.1. OVERVIEW
    9.2. END-USER MARKET FORECASTS AND ANALYSIS
    9.3. BIOPHARMACEUTICAL COMPANIES
    9.3.1. Overview
    9.3.2. Biopharmaceutical Companies Market Forecast and Analysis
    9.4. CLINICAL RESEARCH ORGANIZATIONS/CONTRACT RESEARCH ORGANIZATIONS
    9.4.1. Overview
    9.4.2. Clinical Research Organizations/Contract Research Organizations Market Forecast and Analysis
    9.5. CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO)
    9.5.1. Overview
    9.5.2. Contract Development and Manufacturing Organization (CDMO) Market Forecast and Analysis
    10. PHARMACOGENOMICS MARKET REVENUE AND FORECASTS TO 2028 – GEOGRAPHICAL ANALYSIS
    10.1. NORTH AMERICA
    10.1.1 North America Pharmacogenomics Market Overview
    10.1.2 North America Pharmacogenomics Market Forecasts and Analysis
    10.1.3 North America Pharmacogenomics Market Forecasts and Analysis - By Technology
    10.1.4 North America Pharmacogenomics Market Forecasts and Analysis - By Application
    10.1.5 North America Pharmacogenomics Market Forecasts and Analysis - By End-User
    10.1.6 North America Pharmacogenomics Market Forecasts and Analysis - By Countries
    10.1.6.1 United States Pharmacogenomics Market
    10.1.6.1.1 United States Pharmacogenomics Market by Technology
    10.1.6.1.2 United States Pharmacogenomics Market by Application
    10.1.6.1.3 United States Pharmacogenomics Market by End-User
    10.1.6.2 Canada Pharmacogenomics Market
    10.1.6.2.1 Canada Pharmacogenomics Market by Technology
    10.1.6.2.2 Canada Pharmacogenomics Market by Application
    10.1.6.2.3 Canada Pharmacogenomics Market by End-User
    10.1.6.3 Mexico Pharmacogenomics Market
    10.1.6.3.1 Mexico Pharmacogenomics Market by Technology
    10.1.6.3.2 Mexico Pharmacogenomics Market by Application
    10.1.6.3.3 Mexico Pharmacogenomics Market by End-User
    10.2. EUROPE
    10.2.1 Europe Pharmacogenomics Market Overview
    10.2.2 Europe Pharmacogenomics Market Forecasts and Analysis
    10.2.3 Europe Pharmacogenomics Market Forecasts and Analysis - By Technology
    10.2.4 Europe Pharmacogenomics Market Forecasts and Analysis - By Application
    10.2.5 Europe Pharmacogenomics Market Forecasts and Analysis - By End-User
    10.2.6 Europe Pharmacogenomics Market Forecasts and Analysis - By Countries
    10.2.6.1 Germany Pharmacogenomics Market
    10.2.6.1.1 Germany Pharmacogenomics Market by Technology
    10.2.6.1.2 Germany Pharmacogenomics Market by Application
    10.2.6.1.3 Germany Pharmacogenomics Market by End-User
    10.2.6.2 France Pharmacogenomics Market
    10.2.6.2.1 France Pharmacogenomics Market by Technology
    10.2.6.2.2 France Pharmacogenomics Market by Application
    10.2.6.2.3 France Pharmacogenomics Market by End-User
    10.2.6.3 Italy Pharmacogenomics Market
    10.2.6.3.1 Italy Pharmacogenomics Market by Technology
    10.2.6.3.2 Italy Pharmacogenomics Market by Application
    10.2.6.3.3 Italy Pharmacogenomics Market by End-User
    10.2.6.4 Spain Pharmacogenomics Market
    10.2.6.4.1 Spain Pharmacogenomics Market by Technology
    10.2.6.4.2 Spain Pharmacogenomics Market by Application
    10.2.6.4.3 Spain Pharmacogenomics Market by End-User
    10.2.6.5 United Kingdom Pharmacogenomics Market
    10.2.6.5.1 United Kingdom Pharmacogenomics Market by Technology
    10.2.6.5.2 United Kingdom Pharmacogenomics Market by Application
    10.2.6.5.3 United Kingdom Pharmacogenomics Market by End-User
    10.3. ASIA-PACIFIC
    10.3.1 Asia-Pacific Pharmacogenomics Market Overview
    10.3.2 Asia-Pacific Pharmacogenomics Market Forecasts and Analysis
    10.3.3 Asia-Pacific Pharmacogenomics Market Forecasts and Analysis - By Technology
    10.3.4 Asia-Pacific Pharmacogenomics Market Forecasts and Analysis - By Application
    10.3.5 Asia-Pacific Pharmacogenomics Market Forecasts and Analysis - By End-User
    10.3.6 Asia-Pacific Pharmacogenomics Market Forecasts and Analysis - By Countries
    10.3.6.1 Australia Pharmacogenomics Market
    10.3.6.1.1 Australia Pharmacogenomics Market by Technology
    10.3.6.1.2 Australia Pharmacogenomics Market by Application
    10.3.6.1.3 Australia Pharmacogenomics Market by End-User
    10.3.6.2 China Pharmacogenomics Market
    10.3.6.2.1 China Pharmacogenomics Market by Technology
    10.3.6.2.2 China Pharmacogenomics Market by Application
    10.3.6.2.3 China Pharmacogenomics Market by End-User
    10.3.6.3 India Pharmacogenomics Market
    10.3.6.3.1 India Pharmacogenomics Market by Technology
    10.3.6.3.2 India Pharmacogenomics Market by Application
    10.3.6.3.3 India Pharmacogenomics Market by End-User
    10.3.6.4 Japan Pharmacogenomics Market
    10.3.6.4.1 Japan Pharmacogenomics Market by Technology
    10.3.6.4.2 Japan Pharmacogenomics Market by Application
    10.3.6.4.3 Japan Pharmacogenomics Market by End-User
    10.3.6.5 South Korea Pharmacogenomics Market
    10.3.6.5.1 South Korea Pharmacogenomics Market by Technology
    10.3.6.5.2 South Korea Pharmacogenomics Market by Application
    10.3.6.5.3 South Korea Pharmacogenomics Market by End-User
    10.3.6.6 Indonesia Pharmacogenomics Market
    10.3.6.6.1 Indonesia Pharmacogenomics Market by Technology
    10.3.6.6.2 Indonesia Pharmacogenomics Market by Application
    10.3.6.6.3 Indonesia Pharmacogenomics Market by End-User
    10.4. MIDDLE EAST AND AFRICA
    10.4.1 Middle East and Africa Pharmacogenomics Market Overview
    10.4.2 Middle East and Africa Pharmacogenomics Market Forecasts and Analysis
    10.4.3 Middle East and Africa Pharmacogenomics Market Forecasts and Analysis - By Technology
    10.4.4 Middle East and Africa Pharmacogenomics Market Forecasts and Analysis - By Application
    10.4.5 Middle East and Africa Pharmacogenomics Market Forecasts and Analysis - By End-User
    10.4.6 Middle East and Africa Pharmacogenomics Market Forecasts and Analysis - By Countries
    10.4.6.1 South Africa Pharmacogenomics Market
    10.4.6.1.1 South Africa Pharmacogenomics Market by Technology
    10.4.6.1.2 South Africa Pharmacogenomics Market by Application
    10.4.6.1.3 South Africa Pharmacogenomics Market by End-User
    10.4.6.2 Saudi Arabia Pharmacogenomics Market
    10.4.6.2.1 Saudi Arabia Pharmacogenomics Market by Technology
    10.4.6.2.2 Saudi Arabia Pharmacogenomics Market by Application
    10.4.6.2.3 Saudi Arabia Pharmacogenomics Market by End-User
    10.4.6.3 U.A.E Pharmacogenomics Market
    10.4.6.3.1 U.A.E Pharmacogenomics Market by Technology
    10.4.6.3.2 U.A.E Pharmacogenomics Market by Application
    10.4.6.3.3 U.A.E Pharmacogenomics Market by End-User
    10.5. SOUTH AND CENTRAL AMERICA
    10.5.1 South and Central America Pharmacogenomics Market Overview
    10.5.2 South and Central America Pharmacogenomics Market Forecasts and Analysis
    10.5.3 South and Central America Pharmacogenomics Market Forecasts and Analysis - By Technology
    10.5.4 South and Central America Pharmacogenomics Market Forecasts and Analysis - By Application
    10.5.5 South and Central America Pharmacogenomics Market Forecasts and Analysis - By End-User
    10.5.6 South and Central America Pharmacogenomics Market Forecasts and Analysis - By Countries
    10.5.6.1 Brazil Pharmacogenomics Market
    10.5.6.1.1 Brazil Pharmacogenomics Market by Technology
    10.5.6.1.2 Brazil Pharmacogenomics Market by Application
    10.5.6.1.3 Brazil Pharmacogenomics Market by End-User
    10.5.6.2 Argentina Pharmacogenomics Market
    10.5.6.2.1 Argentina Pharmacogenomics Market by Technology
    10.5.6.2.2 Argentina Pharmacogenomics Market by Application
    10.5.6.2.3 Argentina Pharmacogenomics Market by End-User
    11. INDUSTRY LANDSCAPE
    11.1. MERGERS AND ACQUISITIONS
    11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    11.3. NEW PRODUCT LAUNCHES
    11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
    12. PHARMACOGENOMICS MARKET, KEY COMPANY PROFILES
    12.1. ABBOTT.
    12.1.1. Key Facts
    12.1.2. Business Description
    12.1.3. Products and Services
    12.1.4. Financial Overview
    12.1.5. SWOT Analysis
    12.1.6. Key Developments
    12.2. BIOMéRIEUX SA
    12.2.1. Key Facts
    12.2.2. Business Description
    12.2.3. Products and Services
    12.2.4. Financial Overview
    12.2.5. SWOT Analysis
    12.2.6. Key Developments
    12.3. ASTRAZENECA
    12.3.1. Key Facts
    12.3.2. Business Description
    12.3.3. Products and Services
    12.3.4. Financial Overview
    12.3.5. SWOT Analysis
    12.3.6. Key Developments
    12.4. BAYER AG
    12.4.1. Key Facts
    12.4.2. Business Description
    12.4.3. Products and Services
    12.4.4. Financial Overview
    12.4.5. SWOT Analysis
    12.4.6. Key Developments
    12.5. BD
    12.5.1. Key Facts
    12.5.2. Business Description
    12.5.3. Products and Services
    12.5.4. Financial Overview
    12.5.5. SWOT Analysis
    12.5.6. Key Developments
    12.6. BIO-RAD LABORATORIES, INC.
    12.6.1. Key Facts
    12.6.2. Business Description
    12.6.3. Products and Services
    12.6.4. Financial Overview
    12.6.5. SWOT Analysis
    12.6.6. Key Developments
    12.7. F. HOFFMANN-LA ROCHE LTD
    12.7.1. Key Facts
    12.7.2. Business Description
    12.7.3. Products and Services
    12.7.4. Financial Overview
    12.7.5. SWOT Analysis
    12.7.6. Key Developments
    12.8. ILLUMINA, INC.
    12.8.1. Key Facts
    12.8.2. Business Description
    12.8.3. Products and Services
    12.8.4. Financial Overview
    12.8.5. SWOT Analysis
    12.8.6. Key Developments
    12.9. QIAGEN.
    12.9.1. Key Facts
    12.9.2. Business Description
    12.9.3. Products and Services
    12.9.4. Financial Overview
    12.9.5. SWOT Analysis
    12.9.6. Key Developments
    12.10. THERMO FISHER SCIENTIFIC INC.
    12.10.1. Key Facts
    12.10.2. Business Description
    12.10.3. Products and Services
    12.10.4. Financial Overview
    12.10.5. SWOT Analysis
    12.10.6. Key Developments
    13. APPENDIX
    13.1. ABOUT THE INSIGHT PARTNERS
    13.2. GLOSSARY OF TERMS

    The List of Companies

    1. Abbott. 
    2. bioMérieux SA
    3. AstraZeneca
    4. Bayer AG
    5. BD
    6. Bio-Rad Laboratories, Inc.
    7. F. Hoffmann-La Roche Ltd
    8. Illumina, Inc.
    9. QIAGEN.
    10. Thermo Fisher Scientific Inc.

    TIPRE00007564
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Pricing
    • $3000
    • $4550
    • $6550
    • $8550

        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount   Speak to Analyst